We are an experienced multi-disciplinary clinical academic team, conducting translational research in the field of thrombosis and haemostasis. Our group’s research is focused on 4 key themes:
Research completed under this theme include:
Currently, under this theme, we have recently completed recruitment and are analysing the findings from the Follow-up In Rivaroxaban patientS in seTting of thromboembolism registry. The aim of the FIRST Registry is to study the incidence of long-term complications (VTE, PTS and CTEPH) for VTE treated with rivaroxaban without bridging heparin (up to 5 years) in routine clinical practice. Links to early findings from FIRST: Experience of rivaroxaban in the obese
Research completed under this theme include:
Currently the following study is being undertaken under this theme:
Abnormal uterine bleeding in women PrescribEd anticoagulant theRapy – understandIng wOmen’s experiences and Developing a consensus on management – the PERIOD study
Research completed under this theme include:
Research completed under this theme include: